TROY EDWARD WILSON

CIK 1589597 · President and CEO · last filed 2026-03-25

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$8.00M

Companies

5

Total Filings

67

Lifetime Open-Market Net

-$24.78M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
KURA President and CEO 714,650 $9.05 $6.47M -$18.19M 30 2026-03-25
Avidity Biosciences, Inc. (RNAM) Delisted Director 0 $0 1 2026-02-27
RNA Director 97,636 $12.37 $1.21M -$5.75M 10 2025-09-09
PBYI Director 43,950 $7.33 $322.2K -$836.0K 20 2025-06-17
Zosano Pharma Corp (ZSAN) Delisted Director 3,000 $0.56 $1.7K $0 5 2019-07-18

Recent Filings · Page 5 of 7

67 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2020-06-16 RNA Conv (C) +189,042 $0 EDGAR
2020-06-15 PBYI Sell (S) −25,245 -$251.7K EDGAR
2020-06-11 PBYI Grant (A) +25,748 $0 EDGAR
2020-02-12 KURA Exer (M) +28,096 $136.5K EDGAR
2020-02-03 KURA Grant (A) $0 EDGAR
2019-07-18 Zosano Pharma Corp (ZSAN) Delisted Grant (A) $0 EDGAR
2019-06-12 PBYI Grant (A) +19,423 $0 EDGAR
2019-01-24 KURA Grant (A) $0 EDGAR
2018-11-09 KURA Exer (M) +26,041 $125.0K EDGAR
2018-06-14 PBYI Grant (A) +5,822 $0 EDGAR
Showing 4150 of 67
Page 5 of 7
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.